Bodycote (LON:BOY – Get Free Report)‘s stock had its “neutral” rating restated by investment analysts at JPMorgan Chase & Co. in a research report issued to clients and investors on Tuesday, MarketBeat.com reports.
A number of other research analysts also recently issued reports on BOY. Berenberg Bank reiterated a “buy” rating and issued a GBX 800 price target on shares of Bodycote in a report on Wednesday, July 30th. Royal Bank Of Canada raised their price objective on Bodycote from GBX 650 to GBX 775 and gave the company an “outperform” rating in a research report on Thursday, July 31st. Peel Hunt reiterated a “buy” rating and issued a GBX 845 target price on shares of Bodycote in a report on Tuesday, November 18th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on shares of Bodycote from GBX 860 to GBX 835 and set a “buy” rating on the stock in a report on Tuesday, November 18th. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of GBX 771.
Check Out Our Latest Research Report on BOY
Bodycote Stock Performance
About Bodycote
The leading provider of heat treatment and specialist thermal processing services worldwide.
Heat treatment encompasses a variety of techniques and specialist engineering processes which improve the properties of metals and alloys and extend the life of components and is a vital part of any manufacturing process.
Bodycote is uniquely placed via our global network and the experience and knowledge of our people to offer high quality, reliable and cost-effective services to manufacturers whatever their size or market sector.
Read More
- Five stocks we like better than Bodycote
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Why Gold Loves Trump as Much as Trump Loves Gold
- Best Stocks Under $10.00
- Google’s Gemini 3 Sends Broadcom Soaring: TPUs Take Center Stage
- What Investors Need to Know About Upcoming IPOs
- Palantir Isn’t Just Riding the AI Boom—It’s Orchestrating It
Receive News & Ratings for Bodycote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bodycote and related companies with MarketBeat.com's FREE daily email newsletter.
